Synthesis of Polycyclic Imidazoles via α-C–H/N–H Annulation of Alicyclic Amines
Synthesis · 01.08.2023 · 55 (15) · 2343-2352
DOI: 10.1055/a-2022-1511 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthesis, erschienen am 01.08.2023. Verfasst von Subhradeep Dutta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Heterocyclic Compounds, Department of Chemistry, University of Florida, Gainesville, Florida 32611, United States. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Secondary alicyclic amines are converted into their corresponding ring-fused imidazoles in a simple procedure consisting of oxidative imine formation followed by a van Leusen reaction. Amines with an existing α-substituent undergo regioselective ring-fusion at the α′-position. This method was utilized in a synthesis of fadrozole.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Heterocyclic Compounds, Department of Chemistry, University of Florida, Gainesville, Florida 32611, United States.
Förderung
- NIGMS NIH HHS
- NIH HHS
- National Institute of General Medical Sciences
- National Institutes of Health
Zitieren
APA
Dutta, S., Bhatt, K., Cuffel, F., & Seidel, D. (2023). Synthesis of Polycyclic Imidazoles via α-C–H/N–H Annulation of Alicyclic Amines. Synthesis, 55(15), 2343-2352. https://doi.org/10.1055/a-2022-1511
Vancouver
Dutta S, Bhatt K, Cuffel F, Seidel D. Synthesis of Polycyclic Imidazoles via α-C–H/N–H Annulation of Alicyclic Amines. Synthesis. 2023;55(15):2343-2352. doi:10.1055/a-2022-1511
BibTeX
@article{Dutta2023,
author = {Dutta, Subhradeep and Bhatt, Kamal and Cuffel, Fabian and Seidel, Daniel},
title = {Synthesis of Polycyclic Imidazoles via α-C–H/N–H Annulation of Alicyclic Amines},
journal = {Synthesis},
year = {2023},
volume = {55},
number = {15},
pages = {2343--2352},
doi = {10.1055/a-2022-1511}
}
EUVIMED